PAAMCP
ECYT

Pacific Alternative Asset Management Company (PAAMCO)’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,048
Closed -$61K – 215
2014
Q3 		$61K Sell
10,048
-512,752
-98% -$3.5M 0.01% 200
2014
Q2 		$3.44M Buy
522,800
+464,690
+800% +$5.23M 0.41% 65
2014
Q1 		$1.38M Buy
+58,110
New +$843K 0.24% 76

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s ECYT Position: Q4 2014 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2014, closing a stake of 10,048 shares — an estimated $61K sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in ECYT in Q1 2014 and held it in 3 quarters. The position peaked at $3.44M in Q2 2014. 100 funds tracked by Wall St. Rank hold ECYT as of Q4 2014.

  • Pacific Alternative Asset Management Company (PAAMCO) reported no remaining Endocyte, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Pacific Alternative Asset Management Company (PAAMCO) sold 10,048 Endocyte, Inc. Common Stock shares in Q4 2014, an estimated $61K.
  • Pacific Alternative Asset Management Company (PAAMCO) first reported a position in Endocyte, Inc. Common Stock in Q1 2014 and held it in 3 quarters.
  • Pacific Alternative Asset Management Company (PAAMCO)'s Endocyte, Inc. Common Stock position peaked at $3.44M in Q2 2014.
  • 100 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2014.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q4 2014, filed 13 Feb 2015.